Crossmark World Holdings Inc. boosted its stake in Humana Inc. (NYSE:HUM – Free Report) by 5.0% within the third quarter, in response to its most up-to-date disclosure with the Securities and Change Fee. The fund owned 8,153 shares of the insurance coverage supplier’s inventory after buying an extra 388 shares throughout the quarter. Crossmark World Holdings Inc.’s holdings in Humana had been value $2,583,000 as of its most up-to-date SEC submitting.
Numerous different institutional traders and hedge funds have additionally added to or lowered their stakes in HUM. Envestnet Portfolio Options Inc. elevated its holdings in Humana by 137.6% within the first quarter. Envestnet Portfolio Options Inc. now owns 4,801 shares of the insurance coverage supplier’s inventory valued at $1,665,000 after buying an extra 2,780 shares over the last quarter. Sei Investments Co. elevated its holdings in shares of Humana by 0.4% within the first quarter. Sei Investments Co. now owns 61,897 shares of the insurance coverage supplier’s inventory value $21,462,000 after buying an extra 264 shares within the final quarter. Avantax Advisory Companies Inc. elevated its holdings in shares of Humana by 11.2% within the first quarter. Avantax Advisory Companies Inc. now owns 2,721 shares of the insurance coverage supplier’s inventory value $943,000 after buying an extra 275 shares within the final quarter. ProShare Advisors LLC elevated its holdings in shares of Humana by 3.4% within the first quarter. ProShare Advisors LLC now owns 19,962 shares of the insurance coverage supplier’s inventory value $6,921,000 after buying an extra 658 shares within the final quarter. Lastly, BNP PARIBAS ASSET MANAGEMENT Holding S.A. elevated its holdings in shares of Humana by 356.0% within the first quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 87,939 shares of the insurance coverage supplier’s inventory value $30,490,000 after buying an extra 68,655 shares within the final quarter. Institutional traders personal 92.38% of the corporate’s inventory.
Wall Road Analysts Forecast Development
A number of equities analysis analysts have issued stories on the corporate. TD Cowen elevated their value goal on Humana from $261.00 to $268.00 and gave the inventory a “maintain” score in a report on Monday, November 4th. Jefferies Monetary Group downgraded Humana from a “purchase” score to a “maintain” score and lowered their value goal for the inventory from $519.00 to $253.00 in a report on Monday, October seventh. Royal Financial institution of Canada lowered their value goal on Humana from $400.00 to $265.00 and set an “outperform” score for the corporate in a report on Tuesday, October eighth. Cantor Fitzgerald restated a “impartial” score and issued a $395.00 value goal on shares of Humana in a report on Tuesday, October 1st. Lastly, JPMorgan Chase & Co. upped their value goal on Humana from $332.00 to $396.00 and gave the inventory a “impartial” score in a analysis report on Wednesday, August twenty first. Twenty funding analysts have rated the inventory with a maintain score and 6 have given a purchase score to the inventory. Based mostly on information from MarketBeat.com, the corporate presently has a median score of “Maintain” and a median goal value of $315.86.
Learn Our Newest Inventory Evaluation on HUM
Humana Inventory Efficiency
HUM opened at $280.06 on Wednesday. Humana Inc. has a 12-month low of $213.31 and a 12-month excessive of $527.18. The inventory has a market cap of $33.72 billion, a price-to-earnings ratio of 24.81, a PEG ratio of two.28 and a beta of 0.52. The enterprise has a 50 day shifting common of $287.94 and a 200-day shifting common of $332.62. The corporate has a fast ratio of 1.76, a present ratio of 1.76 and a debt-to-equity ratio of 0.67.
Humana (NYSE:HUM – Get Free Report) final launched its quarterly earnings information on Wednesday, October thirtieth. The insurance coverage supplier reported $4.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.48 by $0.68. Humana had a return on fairness of 13.20% and a web margin of 1.18%. The corporate had income of $29.30 billion throughout the quarter, in comparison with analysts’ expectations of $28.66 billion. On common, equities analysis analysts count on that Humana Inc. will put up 15.83 earnings per share for the present 12 months.
Humana Dividend Announcement
The corporate additionally lately introduced a quarterly dividend, which will likely be paid on Friday, January thirty first. Stockholders of report on Tuesday, December thirty first will likely be paid a dividend of $0.885 per share. The ex-dividend date is Tuesday, December thirty first. This represents a $3.54 dividend on an annualized foundation and a dividend yield of 1.26%. Humana’s dividend payout ratio (DPR) is at the moment 31.36%.
Humana Profile
Humana Inc, along with its subsidiaries, offers medical and specialty insurance coverage merchandise in the US. It operates by way of two segments, Insurance coverage and CenterWell. The corporate provides medical and supplemental profit plans to people. It has a contract with Facilities for Medicare and Medicaid Companies to manage the Restricted Revenue Newly Eligible Transition prescription drug plan program; and contracts with numerous states to offer Medicaid, twin eligible, and long-term help companies advantages.
Featured Tales
Wish to see what different hedge funds are holding HUM? Go to HoldingsChannel.com to get the most recent 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Obtain Information & Scores for Humana Day by day – Enter your electronic mail handle beneath to obtain a concise each day abstract of the most recent information and analysts’ rankings for Humana and associated corporations with MarketBeat.com’s FREE each day electronic mail publication.
